Fresenius | FRE - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Fresenius

Fresenius reported EUR13.66B in Current Liabilities for its fiscal quarter ending in December of 2022.


Current Liabilities Change
Akzo Nobel AKZA:NA EUR 5.57B 172M
Alcon AG ALC:SW USD 2.6B 185M
AstraZeneca AZN:LN USD 24.86B 1.43B
BASF BAS:GR EUR 19.69B 746M
Bayer BAYN:GR EUR 34.39B 693M
DaVita Healthcare Partners DVA:US USD 2.57B 54.65M
Demant A/s WDH:DC DKK 11.57B 1.16B
E.ON EOAN:GR EUR 46.58B 9.11B
Essilor EI:FP EUR 8.89B 2.35B
Getinge GETIB:SS SEK 9.52B 1.33B
Givaudan GIVN:VX CHF 1.97B 901M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
GN Store Nord GN:DC DKK 9.02B 2.72B
Hikma Pharmaceutical HIK:LN USD 1.08B 67M
Lonza Group LONN:SW CHF 3.08B 454M
Merck MRK:GR EUR 9.56B 43M
Novartis NOVN:VX USD 30.55B 1.89B
Roche Holding ROG:VX CHF 27.24B 170M
RWE RWE:GR EUR 53.01B 26.67B
Smith & Nephew PLC SN/:LN USD 1.72B 402M